Invention Grant
- Patent Title: Acylated glucagon analogues
-
Application No.: US14843047Application Date: 2015-09-02
-
Publication No.: US10004786B2Publication Date: 2018-06-26
- Inventor: Ditte Riber , Eddi Meier , Jens Rosengren Daugaard , Marie Skovgaard , Jakob Lind Tolborg , Gita Kampen , Camilla Ærteberg Bæk
- Applicant: Zealand Pharma A/S
- Applicant Address: DK Glostrup
- Assignee: Zealand Pharma A/S
- Current Assignee: Zealand Pharma A/S
- Current Assignee Address: DK Glostrup
- Agency: Clark & Elbing LLP
- Priority: EP09251780 20090713; EP10157240 20100322; DK201000412 20100510
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/26 ; C07K14/605 ; A61K47/48
Abstract:
The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes and associated metabolic disorders. In particular, the invention provides novel acylated glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
Public/Granted literature
- US20160120951A1 ACYLATED GLUCAGON ANALOGUES Public/Granted day:2016-05-05
Information query
IPC分类:
